SLC5A2 and Alzheimer disease: We applied this approach to study the systemic effects of sodium-glucose linked transporter-2 (SGLT-2) inhibition on subsequently isolated synaptosomal glucose metabolism in the 5X-FAD mouse model of Alzheimer’s Disease.